Advances in Dendritic Cell-Based Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 30 July 2025 | Viewed by 136
Special Issue Editors
Interests: immune cells involved in health and disease; tumor microenvironment; immunotherapy; cell therapy
Interests: dendritic cell and T cell biology; antibodies and Fc receptors; infectious diseases and vaccinations; tumor therapy
Special Issue Information
Dear Colleagues,
Pharmaceutics is excited to announce a Special Issue on “Advances in Dendritic Cell-based Delivery Systems”. Dendritic cells (DCs) are potent antigen-presenting cells that play a critical role in modulating the immune response, making them a promising platform for therapeutic delivery in cancer immunotherapy, infectious diseases, and autoimmune disorders. Recent advancements in dendritic cell-based delivery systems have focused on improving antigen loading, enhancing DC maturation, and optimizing their migration to lymphoid tissues for precise immune activation. Innovations such as nanocarriers, biomaterials, and genetic engineering have further advanced the potential of DC-based therapies, leading to improved efficacy and safety profiles.
This Special Issue will explore the latest breakthroughs in dendritic cell delivery systems, including methods for antigen delivery, targeting strategies, and clinical applications. Contributions addressing challenges such as scalability, standardization, and the integration of DC-based systems with other immunotherapeutic approaches are particularly encouraged.
In this Special Issue, original research articles and reviews are welcome. We look forward to receiving your contributions.
Dr. Jacqueline Oliva-Ramírez
Dr. Christian Lehmann
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dendritic cells
- cancer immunotherapy
- targeted therapy
- personalized medicine
- tumor microenvironment
- vaccine formulations
- combination therapies
- metabolic reprogramming
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
